Prokidney

Prokidney is a biotechnology company focused on developing innovative therapies for chronic kidney disease (CKD). Their lead product, REACT, is designed to regenerate kidney function and improve the quality of life for patients suffering from CKD. The company aims to address the unmet medical needs in kidney health through advanced research and development, leveraging cutting-edge science and technology. Prokidney is committed to transforming the treatment landscape for kidney disease, providing hope for patients and their families.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#90 in Grand Cayman

#120 in Cayman Islands

Grand Cayman, Cayman Islands

Prokidney

Forward Citations = 4

27 inventors:

Deepak Jain (5 out of 12 patents)

Timothy A Bertram (4 out of 4 patents)

Joydeep Basu (3 out of 9 patents)

4. Kelly Guthrie (3 out of 13 patents)

5. Russell W Kelley (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prokidney. Retrieved from https://idiyas.com/company/prokidney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]